Park Avenue Securities LLC Has $336,000 Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Park Avenue Securities LLC lifted its holdings in ARK Genomic Revolution ETF (BATS:ARKG) by 14.0% during the 1st quarter, Holdings Channel reports. The fund owned 11,667 shares of the company’s stock after acquiring an additional 1,435 shares during the quarter. Park Avenue Securities LLC’s holdings in ARK Genomic Revolution ETF were worth $336,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. BNP Paribas Financial Markets raised its holdings in ARK Genomic Revolution ETF by 112.8% during the 4th quarter. BNP Paribas Financial Markets now owns 1,156,701 shares of the company’s stock worth $37,951,000 after buying an additional 613,063 shares during the period. Goldman Sachs Group Inc. lifted its position in ARK Genomic Revolution ETF by 271.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock worth $21,090,000 after acquiring an additional 469,740 shares during the last quarter. SG Americas Securities LLC lifted its position in ARK Genomic Revolution ETF by 835.6% during the fourth quarter. SG Americas Securities LLC now owns 213,059 shares of the company’s stock worth $6,990,000 after acquiring an additional 190,287 shares during the last quarter. Del Sette Capital Management LLC bought a new position in shares of ARK Genomic Revolution ETF during the fourth quarter worth approximately $3,253,000. Finally, International Assets Investment Management LLC lifted its holdings in ARK Genomic Revolution ETF by 120.1% during the 4th quarter. International Assets Investment Management LLC now owns 107,617 shares of the company’s stock worth $3,280,000 after purchasing an additional 58,715 shares during the last quarter.

ARK Genomic Revolution ETF Trading Down 1.1 %

Shares of BATS ARKG opened at $23.48 on Monday. The firm has a 50 day moving average price of $25.00 and a two-hundred day moving average price of $28.08.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.